Agilent Technologies Revenue 2010-2025 | A
Agilent Technologies annual/quarterly revenue history and growth rate from 2010 to 2025. Revenue can be defined as the amount of money a company receives from its customers in exchange for the sales of goods or services. Revenue is the top line item on an income statement from which all costs and expenses are subtracted to arrive at net income.
- Agilent Technologies revenue for the quarter ending April 30, 2025 was $1.668B, a 6.04% increase year-over-year.
- Agilent Technologies revenue for the twelve months ending April 30, 2025 was $6.628B, a 0.56% increase year-over-year.
- Agilent Technologies annual revenue for 2024 was $6.51B, a 4.73% decline from 2023.
- Agilent Technologies annual revenue for 2023 was $6.833B, a 0.22% decline from 2022.
- Agilent Technologies annual revenue for 2022 was $6.848B, a 8.37% increase from 2021.
| Agilent Technologies Annual Revenue (Millions of US $) |
|
|---|---|
| 2024 | $6,510 |
| 2023 | $6,833 |
| 2022 | $6,848 |
| 2021 | $6,319 |
| 2020 | $5,339 |
| 2019 | $5,163 |
| 2018 | $4,914 |
| 2017 | $4,472 |
| 2016 | $4,202 |
| 2015 | $4,038 |
| 2014 | $4,048 |
| 2013 | $3,894 |
| 2012 | $6,858 |
| 2011 | $6,615 |
| 2010 | $5,444 |
| 2009 | $4,481 |
| Agilent Technologies Quarterly Revenue (Millions of US $) |
|
|---|---|
| 2025-04-30 | $1,668 |
| 2025-01-31 | $1,681 |
| 2024-10-31 | $1,701 |
| 2024-07-31 | $1,578 |
| 2024-04-30 | $1,573 |
| 2024-01-31 | $1,658 |
| 2023-10-31 | $1,688 |
| 2023-07-31 | $1,672 |
| 2023-04-30 | $1,717 |
| 2023-01-31 | $1,756 |
| 2022-10-31 | $1,849 |
| 2022-07-31 | $1,718 |
| 2022-04-30 | $1,607 |
| 2022-01-31 | $1,674 |
| 2021-10-31 | $1,660 |
| 2021-07-31 | $1,586 |
| 2021-04-30 | $1,525 |
| 2021-01-31 | $1,548 |
| 2020-10-31 | $1,483 |
| 2020-07-31 | $1,261 |
| 2020-04-30 | $1,238 |
| 2020-01-31 | $1,357 |
| 2019-10-31 | $1,367 |
| 2019-07-31 | $1,274 |
| 2019-04-30 | $1,238 |
| 2019-01-31 | $1,284 |
| 2018-10-31 | $1,294 |
| 2018-07-31 | $1,203 |
| 2018-04-30 | $1,206 |
| 2018-01-31 | $1,211 |
| 2017-10-31 | $1,189 |
| 2017-07-31 | $1,114 |
| 2017-04-30 | $1,102 |
| 2017-01-31 | $1,067 |
| 2016-10-31 | $1,111 |
| 2016-07-31 | $1,044 |
| 2016-04-30 | $1,019 |
| 2016-01-31 | $1,028 |
| 2015-10-31 | $1,035 |
| 2015-07-31 | $1,014 |
| 2015-04-30 | $963 |
| 2015-01-31 | $1,026 |
| 2014-10-31 | $1,805 |
| 2014-07-31 | $1,009 |
| 2014-04-30 | $988 |
| 2014-01-31 | $1,008 |
| 2013-10-31 | $1,718 |
| 2013-07-31 | $1,652 |
| 2013-04-30 | $1,732 |
| 2013-01-31 | $1,680 |
| 2012-10-31 | $1,767 |
| 2012-07-31 | $1,723 |
| 2012-04-30 | $1,733 |
| 2012-01-31 | $1,635 |
| 2011-10-31 | $1,728 |
| 2011-07-31 | $1,691 |
| 2011-04-30 | $1,677 |
| 2011-01-31 | $1,519 |
| 2010-10-31 | $1,576 |
| 2010-07-31 | $1,384 |
| 2010-04-30 | $1,271 |
| 2010-01-31 | $1,213 |
| 2009-10-31 | $1,167 |
| 2009-07-31 | $1,057 |
| 2009-04-30 | $1,091 |
| 2009-01-31 | $1,166 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Products Manufacturing | $32.622B | $6.510B |
| Agilent Technologies, Inc. is an original equipment manufacturer of a broad-based portfolio of test and measurement products serving multiple end markets. Recently, the company has diversified into new end markets, namely industrial, chemical and electronics markets. The company has three business segments, including Life Sciences & Applied Markets Group (LSAG), Diagnostics and Genomics Group (DGG) and Agilent Cross Lab Group (ACG).The company uses a direct sales model for the distribution of its products, which is supplemented by distributors, resellers, manufacturers' representatives, telesales and electronic commerce, as necessary. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Abbott Laboratories (ABT) | United States | $226.138B | 26.52 |
| Boston Scientific (BSX) | United States | $158.236B | 37.74 |
| Stryker (SYK) | United States | $145.846B | 29.69 |
| EssilorLuxottica (ESLOY) | France | $137.406B | 0.00 |
| Medtronic (MDT) | Ireland | $114.967B | 16.30 |
| Lonza Group Ag (LZAGY) | Switzerland | $49.252B | 0.00 |
| ResMed (RMD) | United States | $42.733B | 30.52 |
| Haleon (HLN) | United Kingdom | $42.722B | 24.39 |
| GE HealthCare Technologies (GEHC) | United States | $32.252B | 15.16 |
| Koninklijke Philips (PHG) | Netherlands | $25.729B | 17.02 |
| Terumo (TRUMY) | Japan | $25.658B | 33.33 |
| Insulet (PODD) | United States | $20.252B | 79.49 |
| Zimmer Biomet Holdings (ZBH) | United States | $18.281B | 11.74 |
| Smith & Nephew SNATS (SNN) | United Kingdom | $13.485B | 0.00 |
| Baxter (BAX) | United States | $11.516B | 8.90 |
| Sunny Optical Technology (SNPTF) | China | $10.417B | 0.00 |
| Demant (WILYY) | Denmark | $8.633B | 0.00 |
| Bio-Rad Laboratories (BIO) | United States | $7.532B | 27.51 |
| Lantheus Holdings (LNTH) | United States | $4.944B | 12.47 |
| Perrigo (PRGO) | Ireland | $3.706B | 9.39 |
| Prestige Consumer Healthcare (PBH) | United States | $3.667B | 16.38 |
| Haemonetics (HAE) | United States | $3.666B | 16.70 |
| Shandong Weigao Medical Polymer (SHWGF) | China | $3.459B | 0.00 |
| Envista Holdings (NVST) | United States | $3.403B | 23.81 |
| ICU Medical (ICUI) | United States | $3.201B | 23.60 |
| LeMaitre Vascular (LMAT) | United States | $1.906B | 42.61 |
| AtriCure (ATRC) | United States | $1.807B | 0.00 |
| QuidelOrtho (QDEL) | United States | $1.630B | 11.21 |
| Green Thumb Industries (GTBIF) | United States | $1.543B | 34.71 |
| Acuren (TIC) | United States | $1.276B | 0.00 |
| AdaptHealth (AHCO) | United States | $1.229B | 12.48 |
| Curaleaf Holdings (CURLF) | Canada | $1.106B | 0.00 |
| Phibro Animal Health (PAHC) | United States | $1.100B | 14.06 |
| Neogen (NEOG) | United States | $1.017B | 16.14 |
| BioLife Solutions (BLFS) | United States | $0.999B | 0.00 |
| InMode (INMD) | Israel | $0.889B | 8.23 |
| Kestra Medical Technologies (KMTS) | United States | $0.795B | 0.00 |
| Valneva SE (VALN) | France | $0.638B | 0.00 |
| Tilray Brands (TLRY) | Canada | $0.612B | 0.00 |
| Evolus (EOLS) | United States | $0.587B | 0.00 |
| Maravai LifeSciences Holdings (MRVI) | United States | $0.578B | 0.00 |
| CeriBell (CBLL) | United States | $0.550B | 0.00 |
| Owens & Minor (OMI) | United States | $0.533B | 4.42 |
| ZimVie (ZIMV) | United States | $0.529B | 20.40 |
| Surmodics (SRDX) | United States | $0.509B | 0.00 |
| SNDL (SNDL) | Canada | $0.431B | 0.00 |
| Capricor Therapeutics (CAPR) | United States | $0.351B | 0.00 |
| Cresco Labs (CRLBF) | United States | $0.344B | 0.00 |
| SEMPERIT AG HLD (SEIGY) | Austria | $0.304B | 0.00 |
| Sanuwave Health (SNWV) | United States | $0.304B | 0.00 |
| Quanterix (QTRX) | United States | $0.302B | 0.00 |
| VAREX IMAGING (VREX) | United States | $0.293B | 10.77 |
| Aurora Cannabis (ACB) | Canada | $0.260B | 77.00 |
| Cerus (CERS) | United States | $0.249B | 0.00 |
| Verano Holdings (VRNOF) | United States | $0.247B | 0.00 |
| Viemed Healthcare (VMD) | United States | $0.240B | 20.23 |
| OraSure Technologies (OSUR) | United States | $0.233B | 0.00 |
| Omeros (OMER) | United States | $0.229B | 0.00 |
| Biote (BTMD) | United States | $0.226B | 6.35 |
| Canopy Growth (CGC) | Canada | $0.226B | 0.00 |
| Brainsway (BWAY) | Israel | $0.221B | 58.60 |
| Sanara MedTech (SMTI) | United States | $0.220B | 0.00 |
| Exagen (XGN) | United States | $0.195B | 0.00 |
| Organigram Global (OGI) | Canada | $0.185B | 0.00 |
| Utah Medical Products (UTMD) | United States | $0.184B | 15.18 |
| Vireo Growth (VREOF) | United States | $0.184B | 0.00 |
| High Tide (HITI) | Canada | $0.179B | 0.00 |
| TriSalus Life Sciences (TLSI) | United States | $0.159B | 0.00 |
| TerrAscend (TSNDF) | Canada | $0.144B | 0.00 |
| Jushi Holdings (JUSHF) | United States | $0.128B | 0.00 |
| FitLife Brands (FTLF) | United States | $0.123B | 15.09 |
| Safety Shot (SHOT) | United States | $0.116B | 0.00 |
| Quipt Home Medical (QIPT) | United States | $0.105B | 0.00 |
| MacroGenics (MGNX) | United States | $0.103B | 0.00 |
| Jin Medical (ZJYL) | China | $0.100B | 0.00 |
| Fonar (FONR) | United States | $0.095B | 12.29 |
| Oramed Pharmaceuticals (ORMP) | United States | $0.085B | 0.00 |
| Veru (VERU) | United States | $0.070B | 0.00 |
| Apyx Medical (APYX) | United States | $0.070B | 0.00 |
| Agape ATP (ATPC) | $0.070B | 0.00 | |
| Cytosorbents (CTSO) | United States | $0.057B | 0.00 |
| ImmuCell (ICCC) | United States | $0.056B | 0.00 |
| Zynex (ZYXI) | United States | $0.052B | 0.00 |
| Modular Medical (MODD) | United States | $0.040B | 0.00 |
| United-Guardian (UG) | United States | $0.037B | 12.80 |
| Nephros (NEPH) | United States | $0.034B | 46.29 |
| Rockwell Medical (RMTI) | United States | $0.034B | 0.00 |
| Allurion Technologies (ALUR) | United States | $0.021B | 0.00 |
| INLIF (INLF) | $0.017B | 0.00 | |
| Trinity Biotech (TRIB) | Ireland | $0.015B | 0.00 |
| Senestech (SNES) | United States | $0.014B | 0.00 |
| Flora Growth (FLGC) | United States | $0.012B | 0.00 |
| Meihua Medical Technologies (MHUA) | China | $0.012B | 0.00 |
| IM Cannabis (IMCC) | Canada | $0.011B | 0.00 |
| Innovative Eyewear (LUCY) | United States | $0.009B | 0.00 |
| Cellectar Biosciences (CLRB) | United States | $0.009B | 0.00 |
| Sharps Technology (STSS) | United States | $0.005B | 0.00 |
| GlucoTrack (GCTK) | United States | $0.003B | 0.00 |
| Akanda (AKAN) | Canada | $0.002B | 0.00 |
| InterCure (INCR) | Israel | $0.000B | 0.00 |
| InVivo Therapeutics Holdings (NVIVQ) | United States | $0.000B | 0.00 |